Sanofi To Publish COVID-19 Vaccine Price In Development With GSK After Phase I/II Trial Results


PARIS: French drug maker Sanofi will announce the price of the potential COVID-19 vaccine it is developing with Britain’s GlaxoSmithKline after it has released Phase I/II results of the trials, vaccines chief Thomas Triomphe said on Thursday.

The company is expected to release the results from the Phase I/II clinical trials this month.

It is also developing a vaccine with U.S. biotech firm Translate Bio, with clinical human trials expected to start this month.

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *